KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $229 | -66.2% | 5,700 | -64.2% | 0.00% | 0.0% |
| Q1 2023 | $678 | +166.9% | 15,900 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $254 | -99.9% | 5,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $199,000 | +136.9% | 5,300 | +165.0% | 0.00% | – |
| Q2 2021 | $84,000 | -23.6% | 2,000 | +11.1% | 0.00% | – |
| Q1 2021 | $110,000 | -12.7% | 1,800 | 0.0% | 0.00% | – |
| Q4 2020 | $126,000 | +82.6% | 1,800 | 0.0% | 0.00% | – |
| Q3 2020 | $69,000 | +3.0% | 1,800 | 0.0% | 0.00% | – |
| Q2 2020 | $67,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |